Trial intelligence / Profile preview

Effects of probiotics on pharmacokinetics of orally administered drugs

jRCTs071230054Completed

Sponsor
Kyushu University Hospital
Start
Oct 2023
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Open-label trial of tacrolimus, valaciclovir, candesartan cilexetil and bacillus subtilis in None (2 arms), sponsored by Kyushu University Hospital. Primary endpoints: Blood drug concentration and Pharmacokinetic parameters. Started Oct 2023; status: completed.

02

Drugs

tacrolimusvalaciclovircandesartan cilexetilbacillus subtilis

Beyond the preview

Go deeper on jRCTs071230054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071230054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call